TriSalus prices $40 mln public stock offering
Source: SeekingAlpha
2026-02-20 08:22:35 ET
More on TriSalus Life Sciences
- TriSalus Life Sciences, Inc. (TLSI) Discusses Innovative Approaches for Thyroid Artery Embolization and Tumor-Targeted Therapies Transcript
- Seeking Alpha’s Quant Rating on TriSalus Life Sciences
- Historical earnings data for TriSalus Life Sciences
- Financial information for TriSalus Life Sciences
Read the full article on Seeking Alpha
For further details see:
TriSalus prices $40 mln public stock offering
TriSalus Life Sciences Inc.
NASDAQ: TLSI
TLSI Trading
5.82% G/L:
$4.64 Last:
132,484 Volume:
$4.33 Open:
TLSI Latest News
March 05, 2026 04:01:00 pm
TriSalus Life Sciences Reports Fourth Quarter and Year-End 2025 Results and Reaffirms 2026 Revenue Guidance
February 25, 2026 04:05:00 pm
TriSalus Life Sciences to Host Fourth Quarter 2025 Financial Results Conference Call
TLSI Stock Data
$227,337,615
36,224,125
3.04%
18
N/A
Medical Equipment & Supplies
Healthcare
US
Westminster
